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We present a male infant born at 40 weeks of gestation 
by elective Caesarean section due to active hepatitis C 
infection of the mother with a viral load of 8’000’000 
IE/ml. This was the first pregnancy of the 20-year-old 
mother. Apart from active hepatitis C infection and 
atopic dermatitis as a child, the mother was healthy, 
and the pregnancy had been uneventful. 
The mother’s hepatitis C had been diagnosed nine 
years earlier and thus far had been untreated as there 
was no higher degree liver fibrosis and treatment is 
contraindicated during pregnancy (1). Serologic scree-
ning was also positive for hepatitis A, negative for 
HIV, syphilis and cytomegalovirus. The family history 
was remarkable for chronic hepatitis C infection from 
intravenous drug abuse in the maternal grandmother.
The boy adapted well with an Apgar score of 9, 9 and 
9 at 1, 5 and 10 minutes respectively. Birth weight, 
length and head circumference were within the 3rd 
and 50th centile. Due to active maternal hepatitis C 
infection, the baby was immediately bathed after birth, 
and the mother decided not to breastfeed her child. 
In the delivery room, multiple round red skin changes 
were noted (Fig. 1). They were a few milli meters in 
size, erosive, plane, moist and did not blanch on 
palpation. The skin lesions were distributed all over 
the body but sparing the hairy scalp, palms and soles. 
No abnormalities were detected in the genital area, 
the oral mucosa and nails.
CASE REPORT
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4In the delivery room, multiple red round skin lesions 
were noted.
Fig. 1
Fig. 2
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On day 2 of life, most of the skin lesions had become 
encrusted.
6Encrusted skin lesion behind the left ear.
Fig. 3
Fig. 4
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Close-up view of encrusted skin lesion.
On the second day of life, the baby’s skin was dry and 
treated with a cream containing glycerin and petro-
leum jelly. Most of the skin lesions had become encru-
sted (Fig. 2 – 4). Nikolsky‘s sign was negative.
The skin changes were not felt to be related to hepa-
titis C infection. The differential diagnosis focused on 
congenital epidermolytic ichthyosis and Langerhans 
cell histiocytosis. Culture of a skin swab grew Staphy-
lococcus epidermidis as part of the normal human skin 
flora. Virology swabs were negative for herpes simplex 
virus 1 and 2. Complete blood count, kidney and liver 
function tests were within normal limits (except for a 
slightly elevated LDH with a value of 1043 U / l and a 
reference range for newborns < 780 U / l ) (2, 3). 
Ultrasound examination of the abdominal organs 
showed no abnormalities. A skin biopsy of the skin 
lesion shown on Fig. 4 was obtained. Histological 
examination showed a crusted epidermis and a 
bandlike dense infiltrate of epithelioid round cells 
in the upper dermis with pronounced epidermotro-
pism. Admixed to the infiltrate, there were some 
eosinophils. On immunohistochemistry, the epithe-
lioid cells expressed S100, CD1a and langerin, which 
are typical markers for Langerhans cell histiocytosis 
(4). Therefore, histological and immunohistological 
analysis confirmed the diagnosis of Langerhans cell 
histiocytosis (Fig. 5, 6). Furthermore, the subgroup 
Hashimoto-Pritzker, also called congenital self-healing 
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reticulohistiocytosis, was suspected because the dia-
gnosis was made directly after birth and there was no 
evidence for further organ involvement.
After discharge from the postnatal ward, the baby had 
regular follow-up visits in the Oncology Department 
of the Children’s Hospital. The oncologist decided 
not to obtain additional imaging studies since regular 
ab dominal ultrasound examinations and a chest x-ray 
did not suggest further organ involvement and the 
baby did well. 
Two months after birth, all skin lesions except a small 
lesion behind the left ear had disappeared. An obser-
vation-only strategy was chosen within the interna-
tional trial LCH-IV (EudraCT Nr. 2011-001699-20). For 
the next five years, follow-up visits every 6 months 
are planned, and the local pediatrician is sensitized to 
early sings of relapse or further organ involvement of 
Langerhans cell histiocytosis.
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Biopsy of the skin lesion shown in Fig. 4: crusted  
epidermis, bandlike dense infiltrate of epitheloid 
round cells in the upper dermis with some eosino-
phils admixed to the infiltrate (H&E staining).
Fig. 5
Fig. 6
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Immune histochemistry: epitheloid cells expressing 
langerin.
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DISCUSSION Newborns can show a variety of skin changes. Most 
of them are benign and transient, and malignancies 
are very rare (5). Langerhans cell histiocytosis is a rare 
disease with an estimated annual incidence of 1 to 2 
cases per million adults and 2 to 9 cases per million 
children (6 – 8). It is a very heterogeneous condition, 
which can first present between birth and adulthood, 
can affect one or several organ systems and can 
manifest in one or multiple episodes (6). Its etiology 
is unknown, and the disease is characterized by a 
clonal expansion of myeloid dendritic Langerhans 
cells, which differ from the skin Langerhans cells (4). 
A skin biopsy is needed for diagnosis (9). 
Due to the heterogeneity of Langerhans cell histio-
cytosis, making a diagnosis it is not trivial (6, 9). In the 
presented case, congenital epidermolytic ichthyosis 
was a differential diagnosis. Congenital epidermolytic 
ichthyosis usually presents at birth with fragile skin, 
blistering and erythroderma (10). Over time, hyperke-
ratosis is more prominent with yellow-brownish hyper-
keratotic plaques (10). Many other differential diagno-
ses to Langerhans cell histiocytosis are described in the 
literature. The main differential diagnoses occurring in 
neonates are listed in Tables 1 and 2 in more detail. 
In addition, other very rare conditions in neonates 
are mentioned in the literature, namely incontinentia 
pigmenti, neonatal disseminated hemangiomatosis, 
congenital leukemia, dermoid cyst, pilomatricoma, 
congenital Spitz nevus, infantile myofibromatosis, 
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congenital fibrosarcoma, erythropoiesis dermica, con-
genital vasculitis and cutaneous lymphoma (11 – 13).
Langerhans cell histiocytosis most often presents in 
children below the age of 5 years (7). Bones and the 
skin are the most frequently involved organs (15, 16). 
Half of the cases, often very young children, present 
with multi-organ disease (9, 17, 18). The disease is 
heterogeneous not only regarding the type of organs 
involved («low-risk» organs including skin, bones, 
lymph nodes and the pituitary vs. «high-risk» organs 
including the hematopoietic system, liver, spleen and 
lungs) but also regarding the number of affected 
organ systems («single-system» vs. «multi-system» 
disease) (8, 9). Management strongly varies according 
to whether high-risk organs are affected and whether 
multi-system disease is present (6, 8, 9). It reaches 
from observation only or curettage of selected sin-
gle bone lesions (with or without intralesional steroid 
injection) to systemic chemotherapy with cytostatic 
drugs (i.e. with various combinations of drugs such 
as vinblastine, mercaptopurine, cytarabine, methot-
rexate, cladribine, and indomethacin) (6, 8, 19). 
Patients with skin-limited Langerhans cell histiocytosis 
have an excellent prognosis with a disease-free survival 
around 90 % and a long-term survival around 100 %; 
in contrast, in patients with multi-organ involvement 
reactivation is common (more than 50 %), and long-
term survival varies between 20 % and 90 % (6, 9, 20). 
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In neonates, there is a harmless and rare form of 
Langerhans cell histiocytosis called Hashimoto-Pritzker 
or congenital self-healing reticulohistiocytosis. It pre-
sents with isolated skin involvement which resolves 
without any treatment within a few months (12). Never-
theless, the patients require careful complete organ 
screening to exclude involvement of other organs 
since in about 40 % of affected neonates multi-organ 
disease can be detected (17, 21). Even in the absence 
of initial multiorgan involvement, close follow-up is 
required as progression to systemic disease is possible 
(17, 22). Accordingly, the harmless Hashimoto-Pritzker 
form can only be diagnosed retrospectively.
See also: COTM 06/2001:  
A newborn with a papulonodular rash at birth.
Disease entity Presentation Course of 
disease
Severity Diagnostics
Erythema  
toxicum  
neonatorum
1 to > 100 
macules 
(1 – 3 cm) with a 
central vesicle 
(1 – 4 mm) or 
pustule, spares 
palms and soles
Transient rash, 
self-limiting, 
recovery within 
3 – 7 days without 
any residual
Benign, physio-
logical, 50 % of 
term newborns
Wright stain: 
numerous  
eosinophils
Pustular  
melanosis
Flaccid, superficial, 
fragile pustules 
(1 – 3 mm), no 
erythema, on 
whole non-hairy 
body including 
palms and soles
Pustules rupture 
and form brown 
crust, heals with 
brown pigmented 
macules which 
can persist for 
3  months
Idiopathic, 
neonate appears 
well
Wright stain: 
predominance 
of neutrophils 
with occasional 
eosinophils
Infantile  
acropustulosis
Sterile vesiculo-
pustules, mainly 
on palms and 
soles
Tiny, red papules 
evolve into 
vesicles and then 
pustules over 24 
hours, excoriation 
results in erosions 
and then crusts, 
heals with post-
inflammatory 
hyperpigmen-
tation, each crop 
lasts for 7 – 14 
days, recurrent 
at intervals of 
2 – 4 weeks
Intensely itchy, 
gradually less 
severe until the 
disease disap-
pears within  
2 years of onset
Smear: pre-
dominance of 
eosinophils and 
later neutrophils
Histopathology: 
circumscribed 
aggregations of 
subcorneal or 
intraepidermal 
neutrophils with 
scanty lympho-
histiocytic 
infiltrates in the 
papillary dermis
Eosinophilic 
pustular  
folliculitis
Crops of pruritic 
annular or poly-
cyclic plaques, 
composed of 
coalescing sterile 
papulopustules, 
on seborrheic 
areas of the 
scalp, face, 
trunk, and  
extremities
Evolving through 
crusted phase of 
5 – 10 days, heals 
with hyperpig-
mented macules 
without scaring
Absence of syste-
mic symptoms, 
recurrent every 
2 – 8 weeks, 
resolves sponta-
neously between 
4 and 36 months
Wright stain: 
abundant  
eosinophils
Histopathology: 
perifollicular 
inflammatory 
infiltrates in der-
mis, composed 
mainly of eosino-
phils, neutrophils 
and mononuclear 
cells, hair follicles 
show spongiotic 
degeneration of 
the outer root 
sheath with 
necrotic center
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Table 1. Differential diagnoses of Langerhans cell histiocytosis in neonates: non-infectious 
pustular dermatoses (12, 14).
Disease entity Presentation Course of 
disease
Severity Diagnostics
Perinatal  
listeria  
monocytogenes
Grey-white 
maculopapules 
with vesicles or 
pustules
Usually asso-
ciated with 
septicemia or 
meningitis
Routine culture 
of CSF can 
detect organism
Congenital 
candidiasis
Discrete pustular 
lesions with 
erythema,  
distributed over 
face, chest, 
trunk, palms and 
soles
Mostly self-
limiting, can 
disseminate
Identification of 
organism in skin 
scraping and 
culture
Herpes simplex 
infection
Vesicles and 
pustules 
(2 – 4  mm) in 
clusters with  
erythema, 
possible shal-
low mucosal 
ulcerations with 
inflammation
Encephalitis 
and dissemi-
nated disease 
is possible and 
associated with 
high mortality
Viral culture can 
detect organism
Tzanck smear: 
presence of 
multinucleated 
giant cells
Neonatal 
varicella
Clear fluid-filled 
vesicles
Later pustular 
and then scab, 
new crops 
appear for 
about 3 – 4 days, 
continuing up to 
7 days
Severe dissemi-
nated varicella is 
possible
Tzanck smear, 
serology and 
immunofluor-
escence 
microscopy 
are diagnostic 
options
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Table 2. Differential diagnoses of Langerhans cell histiocytosis in neonates: infectious pustular 
dermatoses (12, 14).
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